Operating Lease, Payments of Outlook Therapeutics, Inc. from 31 Dec 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Outlook Therapeutics, Inc. annual and quarterly Operating Lease, Payments in USD history and change rate from 31 Dec 2019 to 30 Sep 2025.
  • Outlook Therapeutics, Inc. Operating Lease, Payments for the quarter ending 31 Dec 2024 was $19,329.
  • Outlook Therapeutics, Inc. annual Operating Lease, Payments for 2025 was $77,315, a 433% increase from 2024.
  • Outlook Therapeutics, Inc. annual Operating Lease, Payments for 2024 was $14,514, a 48% decline from 2023.
  • Outlook Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $27,675, a 41% decline from 2022.
Source SEC data
View on sec.gov
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Change (%)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Change (%)

Outlook Therapeutics, Inc. Annual Operating Lease, Payments (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $77,315 +$62,801 +433% 01 Oct 2024 30 Sep 2025 10-K 19 Dec 2025 2025 FY
2024 $14,514 -$13,161 -48% 01 Oct 2023 30 Sep 2024 10-K 19 Dec 2025 2025 FY
2023 $27,675 -$18,977 -41% 01 Oct 2022 30 Sep 2023 10-K 27 Dec 2024 2024 FY
2022 $46,652 -$112,056 -71% 01 Oct 2021 30 Sep 2022 10-K 22 Dec 2023 2023 FY
2021 $158,708 -$28,792 -15% 01 Oct 2020 30 Sep 2021 10-K 29 Dec 2022 2022 FY
2020 $187,500 01 Oct 2019 30 Sep 2020 10-K 23 Dec 2021 2021 FY

Outlook Therapeutics, Inc. Quarterly Operating Lease, Payments (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $19,329 01 Oct 2024 31 Dec 2024 10-Q 14 Feb 2025 2025 Q1
Q4 2022 $11,861 +$339 +2.9% 01 Oct 2022 31 Dec 2022 10-Q 14 Feb 2024 2024 Q1
Q4 2021 $11,522 -$37,228 -76% 01 Oct 2021 31 Dec 2021 10-Q 14 Feb 2023 2023 Q1
Q4 2020 $48,750 +$1,875 +4% 01 Oct 2020 31 Dec 2020 10-Q 14 Feb 2022 2022 Q1
Q4 2019 $46,875 01 Oct 2019 31 Dec 2019 10-Q 14 Feb 2020 2020 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.